These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 5271985)

  • 1. A comparison of ethionamide-cycloserine and ethionamide-pyrazinamide regimens in patients resistant to major chemotherapeutics.
    Vidinel I
    Scand J Respir Dis Suppl; 1970; 71():192-5. PubMed ID: 5271985
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethionamide, pyrazinamide and cycloserine in drug resistant cases.
    Narang RK; Singh SK
    Indian J Chest Dis; 1973 Jan; 15(1):16-20. PubMed ID: 4695462
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of pulmonary tuberculosis with ethionamide, cycloserine and pyrazinamide in Hong Kong.
    Horsfall PA
    Bull Int Union Tuberc; 1972 Aug; 47 Suppl 2():91-100. PubMed ID: 4662516
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combination of ethambutol with ethionamide, cycloserine and-or pyrazynamide in retreatment of pulmonary tuberculosis].
    Kekkaku; 1968 Feb; 43(2):91-5. PubMed ID: 5678013
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pulmonary tuberculosis resistant to streptomycin and isoniazid and treated wtih a combination of ethionamide, pyrazinamide, and cycloserine (200 cases)].
    Bartal M; Nejjar A; Laraki A
    Tunis Med; 1973 Jul; 51(4):237-43. PubMed ID: 4209977
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of chronic polyresistant pulmonary tuberculosis using ethionamide, pyrazinamide and cycloserine].
    Sighart H; Opl G
    Prax Pneumol; 1968 Nov; 22(11):692-8. PubMed ID: 5714048
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of regimens of ethionamide, pyrazinamide and cycloserine in re-treatment of patients with pulmonary tuberculosis.
    Bignall JR; Lind A; Rist N
    Bull Int Union Tuberc; 1969 Aug; 42():7-57. PubMed ID: 5004884
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of treatment of pulmonary tuberculosis in adults with second line drugs].
    Ropek M; Szymański A; Chetkowski A; Tarocińska B
    Gruzlica; 1968 Oct; 36(10):1043-6. PubMed ID: 5710086
    [No Abstract]   [Full Text] [Related]  

  • 9. [Late results of treatment of chronic, cavernous pulmonary tuberculosis with reserve drugs].
    Zierski M; Zachara A
    Gruzlica; 1968; 37(1):31-8. PubMed ID: 5720035
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immediate results of treatment of tuberculosis patients with drugs of the second series].
    Ivanova ES; Komarova AA
    Sov Med; 1967 Jun; 30(6):107-10. PubMed ID: 5611339
    [No Abstract]   [Full Text] [Related]  

  • 11. Cycloserine plus ethionamide plus pyrazinamide in the treatment of patients excreting isoniazid-resistant tubercle bacilli following previous chemotherapy.
    Ramakrishnan CV; Parthasarathy R; Sambamoorthy S; Somasundaram PR; Subbammal S
    Indian J Med Res; 1976 Jan; 64(1):76-82. PubMed ID: 818010
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of pulmonary tuberculosis with reserve drugs in the light of our personal observations].
    Kochnowski G
    Wiad Lek; 1970 Jan; 23(1):9-13. PubMed ID: 4312765
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of cycloserine in different chemotherapy combinations on chronic pulmonary tuberculosis.
    Susteric J
    Scand J Respir Dis Suppl; 1970; 71():159-61. PubMed ID: 5271978
    [No Abstract]   [Full Text] [Related]  

  • 14. [Triple drug regimen with reserve drugs: ETA, PZA and CS in the treatment of chronic pulmonary tuberculosis].
    Wagner J
    Gruzlica; 1966 Mar; 34(3):249-54. PubMed ID: 5947778
    [No Abstract]   [Full Text] [Related]  

  • 15. [On qualitative demonstration of tuberculostatics in the control of taking of drugs].
    Grunert M; Reutgen H; Iwainsky H
    Z Tuberk Erkr Thoraxorg; 1965; 124(3):141-8. PubMed ID: 5899136
    [No Abstract]   [Full Text] [Related]  

  • 16. General survey of the clinical results of treatment of pulmonary tuberculosis with cycloserine in Turkey.
    Ozgen ZS
    Scand J Respir Dis Suppl; 1970; 71():189-91. PubMed ID: 5271984
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative study of specific blood activity in patients with fibrous-cavernous pulmonary tuberculosis during administration of different combinations of antibacterial preparations].
    Mkrtchian SV; Utkin VV; Egorkina ND
    Antibiotiki; 1970 Oct; 15(10):955-7. PubMed ID: 5487860
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of drugs of secondary group in complex therapy of children with chronic tuberculosis].
    Rushchak VA
    Pediatr Akus Ginekol; 1971; 2():24-5. PubMed ID: 4254375
    [No Abstract]   [Full Text] [Related]  

  • 19. Experience with cycloserine.
    Dissmann E
    Scand J Respir Dis Suppl; 1970; 71():239-43. PubMed ID: 5317744
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results of treatment with a combined 3-drug regimen of secondary drugs in chronic cavernous pulmonary tuberculosis. A study under auspices of the International Union against Tuberculosis].
    Zierski M; Zacara A; Woźniak S
    Gruzlica; 1968 Sep; 36(9):809-18. PubMed ID: 4882450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.